The characteristics of episodic migraine vs. chronic migraine at high altitude and the relationship with body mass index, education level and MIDAS

Aim: Migraine is a common neurological disorder which negatively influencing the life quality of life. In a study from Turkey, migraine prevalence was reported to be 16.4%. It was determined that chronic migraine (CM) accounts for 10.8% of overall migraine cases. Some studies alleged that migraine is more prevalent at high altitudes. Furthermore, a relationship has been reported between CM and body mass index (BMI) and education level. We investigated the characteristic features of migraine and their effects on the activities of daily living, as well as the body mass index and sociodemographic characteristics of the patients, who have been diagnosed with migraine in our outpatient clinic in the city center of Erzurum, which is located nearly 2,000 meters above the sea level.Material and Methods: Characteristics of migraine, sociodemographic data, body mass index and MIDAS scoresof 1347 patients aged 18-45 years, who have been living in the city center of Erzurum and have been diagnosed with migraine based on the ICHD-2 in neurology outpatient clinic between December 2012 and October 2015, were retrospectively evaluated. Patients were divided into two groups as episodic and chronic migraine.Results: Of the patients, the mean age was 30.4 (±8.4) years, 81.8% (n=1104) were female, and 32.3% (n=435) had chronic migraine. Statistically significant differences were observed between the two groups in terms of education level, MIDAS scores and BMI (p

PDF

___

1. Global Burden of Disease Study Collaboration. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;386:743-800.
2. Haut SR, Bigal ME, Lipton RB. Chronic disorders with episodic manifestations: Focus on epilepsy and migraine. Lancet Neurol 2006;5:148-57.
3. Goadsby PJ, Sprenger T. Current practice and future directions in the prevention and acute management of migraine. Lancet Neurol 2010;9:285-98.
4. Tkachuk GA, Cottrell CK, Gibson JS, et al. Factors associated with migraine-related quality of life and disability in adolescents: a preliminary investigation. Headache 2003;43:950-5.
5. Laurell K, Artto V, Bendtsen L, et al. Premonitory symptoms in migraine: A cross-sectional study in 2714 persons. Cephalalgia 2016;36:951-9.
6. Güven B, Güven H, Çomoğlu SS. Migraine and yawning. Headache 2018;58:210-6.
7. Silberstein SD, Saper JR, Freitag F. Migraine: Diagnosis and treatment. in: Silberstein SD, Lipton RB, Dalessio DJ (Eds.) Wolff’s headache and other head pain. 7th ed. New York: Oxford University Press; 2001:121-37.
8. Vos T, Flaxman AD, Naghavi M, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the global burden of disease study 2010. Lancet 2012;380:2163-96.
9. Buse DC, Manack AN, Fanning KM, et al. Chronic migraine prevalence, disability, and sociodemographic factors: Results from the American migraine prevalence and prevention study. Headache 2012;52:1456-70.
10. Ertas M, Baykan B, Orhan EK, et al. One-year prevalence and the impact of migraine and tension-type headache in Turkey: a nationwide home-based study in adults. J Headache Pain 2012;13:147-57.
11. Linde M, Edvinsson L, Manandhar K, et al. Migraine associated with altitude: results from a population-based study in Nepal. Eur J Neurol 2017;24:1055-61.
12. Kim SY, Park SP. The role of headache chronicity among predictors contributing to quality of life in patients with migraine: a hospital-based study. J Headache Pain 2014;15:68.
13. Bigal ME, Serrano D, Reed M, et al. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment. Neurology 2008;71:559-66.
14. Lipton RB, Bigal ME, Stewart WF. Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and healthrelated quality of life. Neurology 2005;65:50-8.
15. Bigal ME, Serrano D, Buse D, et al. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 2008;48:1157-68.
16. Buse DC, Rupnow MF, Lipton RB. Assessing and managing all aspects of migraine: migraine attacks, migraine-related functional impairment, common comorbidities, and quality of life. Mayo Clin Proc 2009;84:422-35.
17. Olesen J. International Classification of Headache Disorders, Second Edition (ICHD-2): current status and future revisions. Cephalalgia 2006;26:1409-10.
18. Mulder EJ, Van Baal C, Gaist D, et al. Genetic and environmental influences on migraine: a twin study across six countries. Twin Res 2003;6:422-31.
19. Charles A. The evolution of a migraine attack - a review of recent evidence. Headache 2013;53:413-9. 20. Headache Classification Committee of the International Headache Society (HIS). The international classification of headache disorders, 3rd edition (beta version). Cephalalgia 2013;33:629-808.
21. Solomon GD. Therapeutic advances in migraine. J Clin Pharmacol 1993;33:200-9.
22. Gupta R, Bhatia MS. A report of cranial autonomic symptoms in migraineurs. Cephalalgia 2007;27:22-8.
23. Russell MB, Fenger K, Olesen J. The family history of migraine. Direct versus indirect information. Cephalalgia 1996;16:156-60.
24. Aromaa M, Rautava P, Sillanpaa M, et al. Familial occurrence of headache. Cephalalgia 1999;25:49-52.
25. Natoli JL, Manack A, Dean B, et al. Global prevalence of chronic migraine: a systematic review. Cephalalgia 2010;30:599-609.
26. Castillo J, Muñoz P, Guitera V, et al. Epidemiology of chronic daily headache in the general population. Headache 1999;39:190-6.
27. Scher AI, Stewart WF, Liberman J, Prevalence of frequent headache in a population sample. Headache 1998;38:497-506.
28. Lipton RB, Bigal ME, Diamond M, et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68:343-9.
29. Blumenfeld AM, Varon SF, Wilcox TK, et al. Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia 2011;31:301-15.
30. Buse DC, Manack A, Serrano D, Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers J Neurol Neurosurg Psychiatry 2010;81:428-32.
31. Lipton RB, Stewart WF, Sawyer J, et al. Clinical utility of an instrument assessing migraine disability: The migraine disability assessment (MIDAS) questionnaire. Headache 2001;41:854-61.
32. Lipton RB. Chronic migraine, classification, differential diagnosis, and epidemiology. Headache 2011;2:77-83.
33. Scher AI, Stewart WF, Ricci JA, et al. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003;106:81-9.
34. Scher AI, Midgette LA, Lipton RB. Risk factors for headache chronification. Headache 2008;48:16-25.
35. Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: a population-based study. Neurology 2006;66:545-50.
36. Davis C, Reno E, Maa E, et al. Roach R. History of Migraine Predicts Headache at High Altitude. High Alt Med Biol 2016;17:300-4.
37. Wilson MH, Newman S, Imray CH. The cerebral effects of ascent to high altitudes. Lancet Neurol 2009;8:175-91.
38. Arregui A, Cabrera J, Leon-Velarde F, et al. High prevalence of migraine in a high-altitude population. Neurology 1991;41:1668-9.